Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)Recruiting
NCT05519085Phase 3Updated Aug 21, 2026
Sponsor: Celgene
Relapsed or Refractory Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +24 more
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)Active Not Recruiting
NCT06926842Phase 2Updated Aug 21, 2026
Sponsor: Zealand Pharma
Overweight · Type 2 Diabetes · Obesity
United States
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion CohortActive Not Recruiting
NCT06492174Phase 3Updated Aug 21, 2026
Sponsor: Boston Scientific Corporation
In-Stent Restenosis
United States
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaActive Not Recruiting
NCT06468228Phase 3Updated Aug 21, 2026
Sponsor: AbbVie
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +39 more
A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis SuppurativaCompleted
NCT04901195Phase 3Updated Aug 21, 2026
Sponsor: UCB Biopharma SRL
Hidradenitis Suppurativa
United States, Australia, Belgium, Bulgaria, Canada +14 more
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaRecruiting
NCT07219173Phase 2Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Asthma
United States, Argentina, Brazil, Canada, China +7 more
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruiting
NCT06172478Phase 2Updated Aug 21, 2026
Sponsor: Daiichi Sankyo
Advanced Solid Tumor · Melanoma · Head and Neck Cancer · Gastric Cancer
United States, Australia, Belgium, Canada, China +11 more
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued TreatmentActive Not Recruiting
NCT02962414Phase 3Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Tuberous Sclerosis Complex
United States, Australia, Belgium, Canada, Colombia +13 more
Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine ToolCompleted
NCT05047224NAUpdated Aug 21, 2026
Sponsor: Vanderbilt University Medical Center
Autism Spectrum Disorder
United States
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIRecruiting
NCT07326566Phase 2Updated Aug 21, 2026
Sponsor: Black Diamond Therapeutics, Inc.
Glioblastoma (GBM) · Newly Diagnosed Glioblastoma · GBM · Glioblastoma Multiforme (GBM)
United States
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerRecruiting
NCT07061977Phase 3Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Locally Advanced Cervical Adenocarcinoma · Locally Advanced Cervical Adenosquamous Carcinoma · Locally Advanced Cervical Squamous Cell Carcinoma · Stage IIIA Cervical Cancer FIGO 2018
United States
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)Recruiting
NCT04728893Phase 2Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Hematologic Malignancies · Waldenstroms Macroglobulinaemia · Non-Hodgkins Lymphoma · Chronic Lymphocytic Leukaemia
United States, Argentina, Australia, Brazil, Canada +17 more
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery DiseaseRecruiting
NCT07223593Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Peripheral Arterial Disease
United States, Argentina, Australia, Brazil, Canada +11 more
Characterization of Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse EventsNot Yet Recruiting
NCT07767448NAUpdated Aug 21, 2026
Sponsor: Stanford University
Cancer
United States
TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement StudyCompleted
NCT05002998Phase 4Updated Aug 21, 2026
Sponsor: Amgen
Thyroid Eye Disease
United States, France, Germany, Italy, Spain +1 more
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut SyndromeRecruiting
NCT05066217Phase 3Updated Aug 21, 2026
Sponsor: Epygenix
Lennox Gastaut Syndrome
United States, China, Italy, Poland, Romania +2 more
Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous DiseaseActive Not Recruiting
NCT06876363Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Ensoma
X-Linked Chronic Granulomatous Disease
United States, United Kingdom
A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and HypertensionCompleted
NCT06785454Phase 2Updated Aug 21, 2026
Sponsor: Mineralys Therapeutics Inc.
Obstructive Sleep Apnea · Hypertension
United States
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant PopulationRecruiting
NCT07006831N/AUpdated Aug 21, 2026
Sponsor: Devyser Inc.
Kidney Disease · Kidney Transplant · Transplant Recipient · Renal Function
United States
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic MigraineRecruiting
NCT05711394Phase 3Updated Aug 21, 2026
Sponsor: AbbVie
Episodic Migraine
United States, Belgium, Canada, Denmark, France +11 more
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back PainRecruiting
NCT07641504Phase 2Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Chronic Pain · Low Back Pain
United States, Puerto Rico
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesActive Not Recruiting
NCT04535401Phase 1Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Colorectal Carcinoma · Advanced Digestive System Carcinoma · Advanced Gastric Carcinoma · Advanced Gastroesophageal Junction Adenocarcinoma
United States
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Recruiting
NCT07165028Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Metabolic Dysfunction-Associated Steatotic Liver Disease
United States, Argentina, Australia, Austria, Belgium +29 more
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsRecruiting
NCT07109726Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Terremoto Biosciences Inc.
Breast Cancer · Endometrial Cancer · Ovarian Cancer · Lung Squamous Cell Carcinoma
United States, Puerto Rico
Individualized AML TreatmentRecruiting
NCT07613385N/AUpdated Aug 21, 2026
Sponsor: City of Hope Medical Center
Relapsed/Refractory Acute Myeloid Leukemia (AML)
United States

Previous page Next page